Is GERN Worth Buying in 2026?

Geron Corp

STOCK PHARMACEUTICAL PREPARATIONS Updated 2026-08-16

Here’s whether Geron Corp (GERN) is worth buying in 2026 — based on weekly-updated price trend, RSI momentum, and return vs. the S&P 500. Our current read: Bullish.

🟢
Bullish

Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+3.95% over 10 days); RSI 50 — healthy momentum range; 3-month momentum positive (+13.9%); rising volume confirms the move (1.32x 30d avg). Currently 26.9% off its 52-week high. Score: +7/7.

Ready to act on this? 📈 Trade on Webull

GERN is in a confirmed uptrend, trading above both its 50-day ($1.37) and 200-day ($1.41) moving averages. An RSI of 49.5 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +1.4% compares to +20.4% for SPY (trailed the market by 19.0%). The current 26.9% drawdown from the 52-week high reflects elevated risk for momentum-based strategies.

$10,000 invested 1 year ago → $10,138 today
vs. S&P 500 (SPY) — same period trailed market by 19.0%

1-Year Price Chart

Daily candles
MA-50 MA-200 Up Down

Signal Check

Above 200-day MA ($1.41)
Above 50-day MA ($1.37)
RSI(14) neutral zone (30–70) — currently 49.5
Positive return (+1.4%)
!Within 10% of period high (−26.9%)
Period Range $1.47
$1.04 $2.01
RSI (14) 49.5
0 · OversoldOverbought · 100

Key Metrics

Price$1.47
Period Return+1.4%
Period High$2.01
Period Low$1.04
Drawdown−26.9%
MA-50$1.37
MA-200$1.41
RSI (14)49.5
Avg Volume (30d)10.6M
vs. SPYtrailed by 19.0%
Return Rank#677 of 1252

Trade GERN

📈 Trade on Webull 📊 Trade on moomoo 💹 Interactive Brokers